Abstract

Histone H3 lysine 4 (K4) methylation is a prevalent mark associated with transcription activation and is mainly catalyzed by the MLL/SET1 family histone methyltransferases. A common feature of the mammalian MLL/SET1 complexes is the presence of three core components (RbBP5, Ash2L and WDR5) and a catalytic subunit containing a SET domain. Unlike most other histone lysine methyltransferases, all four proteins are required for efficient H3 K4 methylation. Despite extensive efforts, mechanisms for how three core components regulate MLL/SET1 methyltransferase activity remain elusive. Here we show that a heterodimer of Ash2L and RbBP5 has intrinsic histone methyltransferase activity. This activity requires the highly conserved SPRY domain of Ash2L and a short peptide of RbBP5. We demonstrate that both Ash2L and the MLL1 SET domain are capable of binding to S-adenosyl-L- [methyl-3H] methionine in the MLL1 core complex. Mutations in the MLL1 SET domain that fail to support overall H3 K4 methylation also compromise SAM binding by Ash2L. Taken together, our results show that the Ash2L/RbBP5 heterodimer plays a critical role in the overall catalysis of MLL1 mediated H3 K4 methylation. The results we describe here provide mechanistic insights for unique regulation of the MLL1 methyltransferase activity. It suggests that both Ash2L/RbBP5 and the MLL1 SET domain make direct contacts with the substrates and contribute to the formation of a joint catalytic center. Given the shared core configuration among all MLL/SET1 family HMTs, it will be interesting to test whether the mechanism we describe here can be generalized to other MLL/SET1 family members in the future.

Highlights

  • IntroductionMLL1 (mixed lineage leukemia) is a mammalian homolog of the Drosophila Trithorax protein (Trx)

  • MLL1 is a mammalian homolog of the Drosophila Trithorax protein (Trx)

  • Given that neither RbBP5 nor Ash2L stably interacts with MLL1SET in the absence of WDR5 [16,22] and that their stimulatory effects to MLL1SET activity are more apparent at high complex concentration, it is likely that some previously uncharacterized transient interactions between Ash2L/RbBP5 and MLL1SET are important for catalyzing H3 K4 methylation

Read more

Summary

Introduction

MLL1 (mixed lineage leukemia) is a mammalian homolog of the Drosophila Trithorax protein (Trx). MLL1 is an H3 K4 histone methyltransferase (HMT) that effect mono-, di-, and tri-methylation through its evolutionarily conserved SET (Su (var), Enhancer of Zeste and Trithorax) domain [1,2,3]. Both MLL1 and H3 K4 methylation are localized broadly across promoter, 59 transcribed and coding regions of the critical target genes and facilitate the recruitment of RNA Pol-II and other chromatin remodeling activities involved in transcription activation [4,5,6]. Understanding the regulation of MLL1 methyltransferase activity bears clinical significance in the treatment of MLL1 deregulated leukemia

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call